Wolfe Research analyst Mike Polark downgraded Edwards Lifesciences to Peer Perform from Outperform with a "fair value" range for the stock at $65-$85.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EW: